EUVIMEDEUVIMED entdecken
Crossref

The patterns and risk factors for relapse in oesophageal squamous cell cancers that achieve pathological complete response to neoadjuvant chemoradiotherapy

Jian Zhong iD, Shuogui Fang, Rui Chen, Jianye Yuan, Xiuying Xie, Ting Lin, Mengzhong Liu, Qianwen Liu, Jianhua Fu

European Journal of Cardio-Thoracic Surgery · 2024

DOI: 10.1093/ejcts/ezae207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Jian Zhong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Gaozhou People's Hospital, Maoming, China. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy, Esophageal Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Sun Yat-sen University Clinical Research 5010 Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES The goal of this study was to investigate the patterns and risk factors for recurrence in patients with oesophageal squamous cell carcinoma with a pathological complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT). METHODS Between January 2008 and December 2018, a total of 96 patients with pCR were enrolled in this study. Lymph nodes with a pCR [LN-ypCR response (+)] were defined as those lymph nodes without residual tumour but with the presence of treatment response to nCRT. Prognostic factors for recurrence-free survival (RFS) were analysed with Cox proportional hazards models and Fine-Gray competing risk models. Lymph node (LN) stations were counted according to the Japan Esophageal Society classification. RESULTS The median follow-up time was 51.5 months. Recurrence occurred in 15 cases (15.6%) with a 9.9-month median time to recurrence and a 15.6-month median survival after recurrence. The majority of recurrent diseases developed within the first 2 years postoperatively. Distant recurrences were detected in 14 cases (14.6%), in which the most common recurrence sites were no.104 LN and the lung, followed by no.16 LN. The mean RFS in the whole cohort was 116.6 months. The LN-ypCR response (+) was identified as the independent prognostic factor for worse RFS in both the multivariate Cox model and the Fine–Gray competing risk model (P = 0.001 and P = 0.002, respectively). CONCLUSIONS Relapse is not rare in oesophageal squamous cell carcinoma cases with pCR after nCRT. Distant recurrences, the predominant pattern of relapse, occur primarily within the first 2 years after oesophagectomy. Patients with pCR with an LN-ypCR response (+) have a higher risk for postoperative recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalEsophageal Squamous Cell CarcinomaNeoadjuvant TherapyEsophageal NeoplasmsHumansMaleFemaleMiddle AgedRisk FactorsAgedRetrospective StudiesEsophagectomyAdultChemoradiotherapyPrognosisLymph NodesLymphatic Metastasis

Stichwörter der Autor:innen

Neoadjuvant chemoradiotherapyOesophageal squamous cell carcinomaPathological complete responseRecurrence

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Gaozhou People's Hospital, Maoming, China.
  • Department of Thoracic Surgery, Sun Yat-san University Cancer Center, Guangzhou, China.
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Guangdong Esophageal Cancer Institute, Guangzhou, China.
  • Department of Radiation Oncology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Department of Radiation Oncology, Sun Yat-san University Cancer Center, Guangzhou, China.

ORCID-Profile: Jian Zhong

Förderung

  • Sun Yat-sen University Clinical Research 5010 Program

Zitieren

APA

Zhong, J., Fang, S., Chen, R., Yuan, J., Xie, X., Lin, T., Liu, M., Liu, Q., & Fu, J. (2024). The patterns and risk factors for relapse in oesophageal squamous cell cancers that achieve pathological complete response to neoadjuvant chemoradiotherapy. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezae207

Vancouver

Zhong J, Fang S, Chen R, Yuan J, Xie X, Lin T, et al. The patterns and risk factors for relapse in oesophageal squamous cell cancers that achieve pathological complete response to neoadjuvant chemoradiotherapy. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezae207

BibTeX
@article{Zhong2024,
  author = {Zhong, Jian and Fang, Shuogui and Chen, Rui and Yuan, Jianye and Xie, Xiuying and Lin, Ting and Liu, Mengzhong and Liu, Qianwen and Fu, Jianhua},
  title = {The patterns and risk factors for relapse in oesophageal squamous cell cancers that achieve pathological complete response to neoadjuvant chemoradiotherapy},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2024},
  doi = {10.1093/ejcts/ezae207}
}
Kostenlos starten →